BLRX

BioLineRX
BLRX

Overview Fund Activity

28 hedge funds and large institutions have $4.01M invested in BioLineRX in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
8
Closed
6
Calls
$86K
Puts
$92K
Net Calls
-$6K
Net Calls Change
-$6K

Top Buyers

1
PHP
1
Parkman Healthcare Partners
Connecticut
$2.06M
2
Citadel Advisors
2
Citadel Advisors
Florida
$127K
3
GWM
3
Geneos Wealth Management
Colorado
$58K
4
VF
4
Virtu Financial
New York
$47K
5
Millennium Management
5
Millennium Management
New York
$42K

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$219K
3
SCM
3
Silverarc Capital Management
Massachusetts
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$637K
5
PVH
5
Psagot Value Holdings
Israel
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CWP
26
Concord Wealth Partners
Virginia
$1K -$4K -20 -80%
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$1K – – –
RE
28
RBC Europe
United Kingdom
$37 -$36 – –
SCM
29
Sio Capital Management
New York
– -$7.65M -68,544 Closed
SCM
30
Silverarc Capital Management
Massachusetts
– -$558K -5,000 Closed
PVH
31
Psagot Value Holdings
Israel
– -$326K -2,925 Closed
SSA
32
Schonfeld Strategic Advisors
New York
– -$213K -1,913 Closed
Goldman Sachs
33
Goldman Sachs
New York
– -$46K -416 Closed
RJA
34
Raymond James & Associates
Florida
– -$35K -315 Closed
1
2